PolyNovo Limited (CALZF)

Market Cap	691.34M
Revenue (ttm)	84.38M
Net Income (ttm)	8.66M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	79.80
Forward PE	77.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	1,691
Open	0.8179
Previous Close	0.8180
Day's Range	0.8178 - 0.8180
52-Week Range	0.6145 - 1.8200
Beta	1.55
RSI	52.95
Earnings Date	Aug 22, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 301
• Stock Exchange: OTCMKTS
• Ticker Symbol: CALZF

Financial Performance

In 2025, PolyNovo's revenue was 128.70 million, an increase of 24.67% compared to the previous year's 103.23 million. Earnings were 13.21 million, an increase of 151.17%.

Financial numbers in AUD